Alnylam Pharmace. buy Raymond James
Summary
This prediction ended on 03.08.25 with a price of €343.00. The BUY prediction by Raymond_James for Alnylam Pharmace. saw massive gains of 38.64%. Raymond_James has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Raymond_James has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -13.930% | -13.930% | 40.381% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Raymond_James for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
30.07.25
30.07.26
12.12.25
Stopped prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
01.11.24
01.11.25
02.11.25

